RE:RE:Korelin ReportListen to the Korelin interview! If you haven't yet - do it, it's hard to even imagine where this company is going. Potential end of the year gbrain cancer trial and then a couple of mystery cancers they've had success with - TLT will be at a crazy valuation if just the bladder cancer comes through. If it becomes a viable alternative treatment for multiple cancers...well pardon my French, but shut the front door!